The stock of Innoviva Inc (NASDAQ:INVA) is a huge mover today! About 834,581 shares traded hands or 24.50% up from the average. Innoviva Inc (NASDAQ:INVA) has declined 21.89% since March 29, 2016 and is downtrending. It has underperformed by 25.36% the S&P500.
The move comes after 7 months positive chart setup for the $1.15 billion company. It was reported on Oct, 31 by Barchart.com. We have $13.87 PT which if reached, will make NASDAQ:INVA worth $391.00 million more.
According to Zacks Investment Research, “Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.”
More recent Innoviva Inc (NASDAQ:INVA) news were published by: Marketwatch.com which released: “Innoviva Inc. NASDAQ: INVA” on May 21, 2011. Also Businesswire.com published the news titled: “Innoviva Reports Third Quarter 2016 Financial Results” on October 27, 2016. Seekingalpha.com‘s news article titled: “Innoviva: On Track To Buy Back The Whole Company” with publication date: February 04, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.